Alectinib restored vision from an eye metastasis of ALK-positive lung cancer

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: ALK-positive.

Metastatic Site: right choroid of the eye; liver; bone; brain

After nearly eight months of response to alectinib, the lung cancer progressed in the liver, bone, and brain; lorlatinib was started, but he died on July 3, 2020.

PubMed CentralRead more →

Stage IV ALK Lung Adenocarcinoma: Amanda's Survivor Story

Patient Info: Amanda Nerstad, Under 40 | Stage IV

Biomarkers: ALK-positive

She achieved a complete metabolic response on alectinib and had shown no evidence of disease since November 2017 while continuing treatment.

MD AndersonRead more →